[Contribution to the study of the therapeutic activity of PSE preparation in postradiation pathology].
D000818:Animals; D006224:Cricetinae; D004920:Erythropoiesis / Q000187:drug effects*; D006801:Humans; D051379:Mice; D011833:Radiation Injuries, Experimental / Q000188:drug therapy*; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D011878:Radiotherapy / Q000009:adverse effects*
D011837:Radiation-Protective Agents
Przyczynek do poznania działania leczniczego preparatu PSE w patologii popromiennej.